Epiva Biosciences has merged with Evelo Biosciences INC to create an immune-microbiome company for the development of therapeutics for cancer, autoimmune and inflammatory diseases.
According to the agreement, the combined company will retain the name of Evelo Biosciences and establish a metasystem combining the microbiome and immune system platforms of both organisations.
Ningbo Medical System Biotechnology has announced its acquirement of an 80% stake in Shanghai Biological Engineering Co. Ltd.
The company expects to acquire it for a purchase consideration of $1.46m.
Martindale Pharmaceuticals has acquired Viridian Pharma Limited in order to expand its product portfolio and support the growth of its hospital initiated medicines product range.
According to the agreement, Viridian Pharma will be combined into Martindale Pharma’s existing growing business.
The acquisition will immediately be accretive to the gross earnings.